Lv1
28 积分 2024-12-05 加入
Sigma ligands as potent inhibitors of Aβ and AβOs in neurons and promising therapeutic agents of Alzheimer's disease
9小时前
已完结
Role of σ1 Receptors in Learning and Memory and Alzheimer’s Disease-Type Dementia
9小时前
待确认
TREM2 in Alzheimer's disease: Structure, function, therapeutic prospects, and activation challenges
16天前
已完结
Phase I, Pharmacokinetic, and Pharmacodynamic Study of AMG 479, a Fully Human Monoclonal Antibody to Insulin-Like Growth Factor Receptor
22天前
已关闭
The effect and safety of levodopa alone versus levodopa sparing therapy for early Parkinson’s disease: a systematic review and meta-analysis
27天前
已完结
Levodopa/carbidopa/entacapone for the treatment of early Parkinson’s disease: a meta-analysis
27天前
已完结
Characterization of the Potent and Highly Selective A2A Receptor Antagonists Preladenant and SCH 412348 [7-[2-[4-2,4-Difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in Rodent Models of Movement Disorders and Depression
1个月前
已完结
Potent, selective, and orally active adenosine A2A receptor antagonists: Arylpiperazine derivatives of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines
1个月前
已完结
P546. Preclinical Characterization and Phase 1 Evaluation of the Tolerability, Pharmacokinetics, and Enzyme Occupancy of MK-8189, a Novel PDE10A Inhibitor
1个月前
已完结
P546. Preclinical Characterization and Phase 1 Evaluation of the Tolerability, Pharmacokinetics, and Enzyme Occupancy of MK-8189, a Novel PDE10A Inhibitor
1个月前
已完结
皖公网安备34019202002308
